Laurent-Puig P - Search Results

1

Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy.

Manceau G, Imbeaud S, Thiébaut R, Liébaert F, Fontaine K, Rousseau F, Génin B, Le Corre D, Didelot A, Vincent M, Bachet JB, Chibaudel B, Bouché O, Landi B, Bibeau F, Leroy K, Penault-Llorca F, Van Laethem JL, Demetter P, Tejpar S, Rossi S, Mosakhani N, Osterlund P, Ristamäki R, Sarhadi V, Knuutila S, Boige V, André T, Laurent-Puig P. Manceau G, et al. Clin Cancer Res. 2014 Jun 15;20(12):3338-47. doi: 10.1158/1078-0432.CCR-13-2750. Epub 2014 Apr 25. Clin Cancer Res. 2014. PMID: 24771647

2

[Genetic alterations associated with hepatocellular carcinoma].

Boige V, Laurent-Puig P. Boige V, et al. Gastroenterol Clin Biol. 1997;21(1):34-44. Gastroenterol Clin Biol. 1997. PMID: 9091389 Review. French. No abstract available.

3

Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype.

Boige V, Laurent-Puig P, Fouchet P, Fléjou JF, Monges G, Bedossa P, Bioulac-Sage P, Capron F, Schmitz A, Olschwang S, Thomas G. Boige V, et al. Cancer Res. 1997 May 15;57(10):1986-90. Cancer Res. 1997. PMID: 9157995

4

Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.

Lecomte T, Berger A, Zinzindohoué F, Micard S, Landi B, Blons H, Beaune P, Cugnenc PH, Laurent-Puig P. Lecomte T, et al. Int J Cancer. 2002 Aug 10;100(5):542-8. doi: 10.1002/ijc.10526. Int J Cancer. 2002. PMID: 12124803

5

Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.

Lecomte T, Ferraz JM, Zinzindohoué F, Loriot MA, Tregouet DA, Landi B, Berger A, Cugnenc PH, Jian R, Beaune P, Laurent-Puig P. Lecomte T, et al. Clin Cancer Res. 2004 Sep 1;10(17):5880-8. doi: 10.1158/1078-0432.CCR-04-0169. Clin Cancer Res. 2004. PMID: 15355920

6

Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.

Zinzindohoué F, Lecomte T, Ferraz JM, Houllier AM, Cugnenc PH, Berger A, Blons H, Laurent-Puig P. Zinzindohoué F, et al. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):594-9. Clin Cancer Res. 2005. PMID: 15701845

7

Consequences of genetic polymorphisms for sirolimus requirements after renal transplant in patients on primary sirolimus therapy.

Anglicheau D, Le Corre D, Lechaton S, Laurent-Puig P, Kreis H, Beaune P, Legendre C, Thervet E. Anglicheau D, et al. Am J Transplant. 2005 Mar;5(3):595-603. doi: 10.1111/j.1600-6143.2005.00745.x. Am J Transplant. 2005. PMID: 15707415 Free article.

8

Clinical value of mitochondrial mutations in colorectal cancer.

Lièvre A, Chapusot C, Bouvier AM, Zinzindohoué F, Piard F, Roignot P, Arnould L, Beaune P, Faivre J, Laurent-Puig P. Lièvre A, et al. J Clin Oncol. 2005 May 20;23(15):3517-25. doi: 10.1200/JCO.2005.07.044. J Clin Oncol. 2005. PMID: 15908662

9

Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers.

Lièvre A, Landi B, Côté JF, Veyrie N, Zucman-Rossi J, Berger A, Laurent-Puig P. Lièvre A, et al. Oncogene. 2005 Nov 3;24(48):7253-6. doi: 10.1038/sj.onc.1208867. Oncogene. 2005. PMID: 16044160

10

[Detection of microsatellite instability in colorectal cancer].

Laurent-Puig P, Landi B, Lièvre A. Laurent-Puig P, et al. Gastroenterol Clin Biol. 2005 Jun-Jul;29(6-7):657-8. doi: 10.1016/s0399-8320(05)82152-9. Gastroenterol Clin Biol. 2005. PMID: 16141998 Free article. French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters